Assured Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Assured Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,358	Closed	-$272K	–	1415
2018 Q1	$272K	Buy	+3,358	New	+$271K	0.01%	928
2016 Q4	–	Sell	-1,198	Closed	-$149K	–	739
2016 Q3	$149K	Buy	1,198 +1,041	+663%	+$123K	﹤0.01%	537
2016 Q2	$17K	Sell	157 -626	-80%	-$72.7K	﹤0.01%	563
2016 Q1	$90K	Buy	+783	New	+$91.9K	﹤0.01%	537

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Assured Investment Management's CBPO Position: Q2 2018 in Review

Assured Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2018, closing a stake of 3,358 shares — an estimated $272K sold.

Assured Investment Management first reported a position in CBPO in Q1 2016 and held it in 4 quarters. The position peaked at $272K in Q1 2018. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2018.

Assured Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
Assured Investment Management sold 3,358 China Biologic Products Holdings, Inc. shares in Q2 2018, an estimated $272K.
Assured Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 4 quarters.
Assured Investment Management's China Biologic Products Holdings, Inc. position peaked at $272K in Q1 2018.
91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2018.

Based on Assured Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.